Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro
<p>Abstract</p> <p>Background</p> <p>The peroxisome proliferator-activated receptor-γ (PPARγ) agonist rosiglitazone has been suggested to exert cardiovascular protection through the improvement of lipid metabolism, anti-inflammation, anti-proliferation etc. However, whether renin-angiotensin system...
Zapisane w:
| Główni autorzy: | , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2011-01-01
|
| Seria: | Cardiovascular Diabetology |
| Dostęp online: | http://www.cardiab.com/content/10/1/10 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|